These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8681353)

  • 1. [Pathophysiologic mechanisms of early changes in renal hemodynamics in diabetes mellitus].
    Komers R
    Cas Lek Cesk; 1996 Mar; 135(5):135-9. PubMed ID: 8681353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats.
    Komers R; Schutzer W; Xue H; Oyama TT; Lindsley JN; Anderson S
    Transl Res; 2007 Dec; 150(6):343-9. PubMed ID: 18022596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Renal hemodynamics and its regulation in recently diagnosed type 1 diabetes mellitus (insulin-dependent diabetes mellitus). The effect of hyperglycemia].
    Pelikánová T; Pinsker P; Smrcková I; Stríbrná L; Dryáková M
    Cas Lek Cesk; 1997 Sep; 136(17):533-8. PubMed ID: 9441014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in metabolic disorders: hypercholesterolaemia and diabetes].
    Strawn WB
    Drugs; 2002; 62 Spec No 1():31-41. PubMed ID: 12036387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Arterial hypertension and diabetic nephropathy].
    Chaignon M; Guedon J
    J Mal Vasc; 1992; 17(4):311-4. PubMed ID: 1494060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Glomerular hyperfiltration in diabetic nephropathy].
    Ito O; Ito S
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():331-5. PubMed ID: 15999729
    [No Abstract]   [Full Text] [Related]  

  • 7. Renal functional reserve in subjects with diabetes mellitus.
    Jones SL; Viberti G
    Semin Nephrol; 1995 Sep; 15(5):475-81. PubMed ID: 8525151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The renal hemodynamic basis of diabetic nephropathy.
    O'Bryan GT; Hostetter TH
    Semin Nephrol; 1997 Mar; 17(2):93-100. PubMed ID: 9148381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion insertion polymorphism of the angiotensin converting enzyme gene and progression of diabetic nephropathy.
    Björck S; Blohmé G; Sylvén C; Mulec H
    Nephrol Dial Transplant; 1997; 12 Suppl 2():67-70. PubMed ID: 9269704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes-induced hyperfiltration in adenosine A(1)-receptor deficient mice lacking the tubuloglomerular feedback mechanism.
    Sällström J; Carlsson PO; Fredholm BB; Larsson E; Persson AE; Palm F
    Acta Physiol (Oxf); 2007 Jul; 190(3):253-9. PubMed ID: 17581137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of KATP channel blocker U37883A on renal function in experimental diabetes mellitus in rats.
    Vallon V; Albinus M; Blach D
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1215-21. PubMed ID: 9732381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current concepts of renal hemodynamics in diabetes.
    Anderson S; Vora JP
    J Diabetes Complications; 1995; 9(4):304-7. PubMed ID: 8573753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The renoprotective action of angiotensin-converting enzyme inhibitors in diabetes.
    Ruggenenti P; Remuzzi G
    Exp Nephrol; 1996; 4 Suppl 1():53-60. PubMed ID: 9001898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term moderate sodium restriction induces relative hyperfiltration in normotensive normoalbuminuric Type I diabetes mellitus.
    Luik PT; Hoogenberg K; Van Der Kleij FG; Beusekamp BJ; Kerstens MN; De Jong PE; Dullaart RP; Navis GJ
    Diabetologia; 2002 Apr; 45(4):535-41. PubMed ID: 12032630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrarenal oxygen in diabetes and a possible link to diabetic nephropathy.
    Palm F
    Clin Exp Pharmacol Physiol; 2006 Oct; 33(10):997-1001. PubMed ID: 17002679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney involvement and disease in patients with diabetes.
    Chiarelli F; Trotta D; Verrotti A; Mohn A
    Panminerva Med; 2003 Mar; 45(1):23-41. PubMed ID: 12682618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary kidney growth and its consequences at the onset of diabetes mellitus.
    Satriano J; Vallon V
    Amino Acids; 2006 Jul; 31(1):1-9. PubMed ID: 16733619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology.
    Wolf G
    Eur J Clin Invest; 2004 Dec; 34(12):785-96. PubMed ID: 15606719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.